Cargando…

It Takes Two to Tango: Potential Prognostic Impact of Circulating TGF-Beta and PD-L1 in Pancreatic Cancer

Background: Pancreatic ductal adenocarcinoma (PDAC) is a highly devastating disease with rising incidence and poor prognosis. The lack of reliable prognostic biomarkers hampers the individual evaluation of the survival and recurrence potential. Methods: Here, we investigate the value of plasma level...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garajová, Ingrid, Cavazzoni, Andrea, Verze, Michela, Minari, Roberta, Pedrazzi, Giuseppe, Balsano, Rita, Gelsomino, Fabio, Valle, Raffaele Dalla, Digiacomo, Graziana, Giovannetti, Elisa, Leonardi, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323895/ https://www.ncbi.nlm.nih.gov/pubmed/35888050 http://dx.doi.org/10.3390/life12070960

Ejemplares similares

Biological Hallmarks and New Therapeutic Approaches for the Treatment of PDAC
por: Digiacomo, Graziana, et al.
Publicado: (2021)

PTEN Alterations as a Potential Mechanism for Tumor Cell Escape from PD-1/PD-L1 Inhibition
por: Cretella, Daniele, et al.
Publicado: (2019)

Synchronous and metachronous colorectal liver metastases: impact of primary tumor location on patterns of recurrence and survival after hepatic resection
por: Garajova, Ingrid, et al.
Publicado: (2021)

The implication of liquid biopsies to predict chemoresistance in pancreatic cancer
por: Pietri, Elisabetta, et al.
Publicado: (2021)

Should patients on levothyroxine therapy be screened for pancreatic cancer?
por: Garajová, Ingrid, et al.
Publicado: (2022)

Small Bowel Adenocarcinoma: From Molecular Insights to Clinical Management
por: Gelsomino, Fabio, et al.
Publicado: (2022)

It takes two to tango
por: Fuchs, Paul Albert
Publicado: (2014)

Role of Cytokines and Other Soluble Factors in Tumor Development: Rationale for New Therapeutic Strategies
por: Cavazzoni, Andrea, et al.
Publicado: (2023)

It Takes Two to Tango: Endothelial TGFβ/BMP Signaling Crosstalk with Mechanobiology
por: Hiepen, Christian, et al.
Publicado: (2020)

It takes two to tango to the melanosome
por: Lakkaraju, Aparna, et al.
Publicado: (2009)

It takes two to tango in the microenvironment!
por: Ursini-Siegel, Josie, et al.
Publicado: (2013)

Lipoprotein secretion: It takes two to TANGO
por: Pfeffer, Suzanne R.
Publicado: (2016)

It takes two to tango: The dance of the permease
por: Kaback, H. Ronald, et al.
Publicado: (2019)

Transforming Growth Factor-Beta Signaling in Cancer-Induced Cachexia: From Molecular Pathways to the Clinics
por: Balsano, Rita, et al.
Publicado: (2022)

A Simple Overview of Pancreatic Cancer Treatment for Clinical Oncologists
por: Garajová, Ingrid, et al.
Publicado: (2023)

The Growing Skyline of Advanced Hepatocellular Carcinoma Treatment: A Review
por: Schipilliti, Francesca Matilde, et al.
Publicado: (2021)

For fission yeast nuclei, it takes two to tango
por: Short, Ben
Publicado: (2015)

Inhibition of RAF dimers: it takes two to tango
por: Cook, Frazer A., et al.
Publicado: (2021)

Pemetrexed Enhances Membrane PD-L1 Expression and Potentiates T Cell-Mediated Cytotoxicity by Anti-PD-L1 Antibody Therapy in Non-Small-Cell Lung Cancer
por: Cavazzoni, Andrea, et al.
Publicado: (2020)

Human longevity: Genetics or Lifestyle? It takes two to tango
por: Passarino, Giuseppe, et al.
Publicado: (2016)

Endobronchial and endoscopic ultrasound: it only takes an echobronchoscope to tango
por: Soo, Chun Ian, et al.
Publicado: (2019)

Potential Role of Exosomes in the Chemoresistance to Gemcitabine and Nab-Paclitaxel in Pancreatic Cancer
por: Comandatore, Annalisa, et al.
Publicado: (2022)

Trastuzumab in the adjuvant setting: concurrent or sequential? It takes two to tango!
por: Verma, Sunil
Publicado: (2008)

It takes two to tango: Ubiquitin and SUMO in the DNA damage response
por: Bologna, Serena, et al.
Publicado: (2013)

It Takes Two to Tango: A New Partner in Amylose Synthesis
por: Sedwick, Caitlin
Publicado: (2015)

It Takes Two to Tango: Coupling of Angiogenesis and Osteogenesis for Bone Regeneration
por: Grosso, Andrea, et al.
Publicado: (2017)

It takes two to tango: NAD(+) and sirtuins in aging/longevity control
por: Imai, Shin-ichiro, et al.
Publicado: (2016)

It takes more than two to tango: mechanosignaling of the endothelial surface
por: Fels, Benedikt, et al.
Publicado: (2020)

YAP/Hippo Pathway and Cancer Immunity: It Takes Two to Tango
por: Matthaios, Dimitrios, et al.
Publicado: (2021)

HIV vaccine: it may take two to tango, but no party time yet
por: Berkhout, Ben, et al.
Publicado: (2009)

Celiac disease TG2 autoantibodies development: it takes two to tango
por: Rossin, Federica, et al.
Publicado: (2020)

It takes two—or more—to tango: Revisiting the role of dopamine transporter oligomerization
por: Gether, Ulrik, et al.
Publicado: (2021)

Tumor-infiltrating lymphocytes for treatment of solid tumors: It takes two to tango?
por: Kazemi, Mohammad Hossein, et al.
Publicado: (2022)

Differential Effects of Tango Versus Dance for PD in Parkinson Disease
por: McNeely, Marie E., et al.
Publicado: (2015)

Tango
Publicado: (2005)

Tango /
por: Mrozek, Slawomir
Publicado: (2004)

Trastuzumab emtansine delays and overcomes resistance to the third-generation EGFR-TKI osimertinib in NSCLC EGFR mutated cell lines
por: La Monica, Silvia, et al.
Publicado: (2017)

Efficacy of the CDK4/6 Dual Inhibitor Abemaciclib in EGFR-Mutated NSCLC Cell Lines with Different Resistance Mechanisms to Osimertinib
por: La Monica, Silvia, et al.
Publicado: (2020)

Tandem Inhibition of PKC in Diαβetic Nephropathy: It Takes Two to Tango?
por: Thallas-Bonke, Vicki, et al.
Publicado: (2013)

Taking two to tango: a role for ghrelin receptor heterodimerization in stress and reward
por: Schellekens, Harriët, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ruaqmqplqhb2hh1lmhq6fk6vo1